260 results on '"Musumeci, Beatrice"'
Search Results
2. Impact of the Noninvasive Diagnostic Algorithm on Clinical Presentation and Prognosis in Cardiac Amyloidosis
3. Comprehensive Geriatric Assessment to Optimize the Management of Older Patients With Transthyretin Cardiac Amyloidosis
4. Renin angiotensin system inhibitors and outcome in patients with takotsubo syndrome: A propensity score analysis of the GEIST registry
5. Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Incident Cancer
6. Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes
7. ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study
8. Statin therapy and outcome in Takotsubo syndrome patients: Results from the multicenter international GEIST registry
9. Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis
10. Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies
11. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value
12. Gender Differences in Takotsubo Syndrome
13. Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis
14. Neurological Disorders in Takotsubo Syndrome: Clinical Phenotypes and Outcomes
15. Age‐Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry
16. A contemporary update on cancer and takotsubo syndrome
17. Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population
18. Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy
19. Smoking influence in Takotsubo syndrome: insights from an international cohort
20. ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study
21. Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy
22. Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy
23. A Plea for Smoking-Free Policies in COVID-19 Times: Cardiovascular Prevention as an Ally in Coronavirus Containment
24. [Rationale and significance of the Italian Network for Cardiac Amyloidosis]
25. Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca
26. Cardioembolic Stroke in Cardiac Amyloidosis: the real challenge lies beyond heart rhythm
27. CE-452775-3 SCAR ARCHITECTURE AS A STRUCTURAL BIOMARKER OF VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: A CARDIAC MAGNETIC RESONANCE STUDY
28. Substrates of Scar-Related Ventricular Arrhythmia in Patients With Hypertrophic Cardiomyopathy
29. Risk stratification in transthyretin-related cardiac amyloidosis
30. Diagnostic pathways to wild‐type transthyretin amyloid cardiomyopathy: a multicentre network study
31. Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy
32. Diagnostic delay in arrhythmogenic cardiomyopathy.
33. Impact of intra-aortic balloon counterpulsation on all-cause mortality among patients with Takotsubo syndrome complicated by cardiogenic shock; results from the German-Italian-Spanish Takotsubo (GEIST) registry.
34. 310 CLINICAL COURSE AND CHARACTERISTICS OF ADVANCED HEART FAILURE ASSOCIATED WITH ARRHYTHMOGENIC CARDIOMYOPATHY
35. 580 INCIDENCE AND FACTORS ASSOCIATED WITH DE NOVO ATRIAL FIBRILLATION IN PATIENTS WITH WILD-TYPE TRANSTHYRETIN CARDIAC AMYLOIDOSIS - A MULTICENTER STUDY
36. 66 MYOCARDIAL EDEMA CONTRIBUTES TO INTERSTITIAL EXPANSION AND ASSOCIATES WITH MECHANICAL AND ELECTROCARDIOGRAPHIC CHANGES IN TAKOTSUBO SYNDROME: A CMR T1 AND T2 MAPPING STUDY
37. Long-Term Outcome of Acute Coronary Syndromes in Young Patients
38. Exploring the influence of takotsubo syndrome on oncologic patients’ mortality
39. Significance of Sarcomere Gene Mutations Analysis in the End-Stage Phase of Hypertrophic Cardiomyopathy
40. Risk of Sudden Death and Outcome in Patients With Hypertrophic Cardiomyopathy With Benign Presentation and Without Risk Factors
41. Subcutaneous implantable cardioverter defibrillator in cardiomyopathies and channelopathies
42. A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE Study
43. Prognostic Implications of Defibrillation Threshold Testing in Patients With Hypertrophic Cardiomyopathy
44. Incidence and risk factors for pacemaker implantation in light‐chain and transthyretin cardiac amyloidosis
45. Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC‐TIVE study, an Italian nationwide survey
46. Clinical translation of genetic testing in TTR Amyloidosis: genotype-phenotype correlations, management of asymptomatic carriers and familial screening
47. 465 Unmasking the prevalence of cardiac amyloidosis in the real world: first insights from the phase 2 of active study, an Italian nationwide survey
48. Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study
49. Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy
50. Impact of intra-aortic balloon counterpulsation on all-cause mortality among patients with Takotsubo syndrome complicated by cardiogenic shock: results from the German-Italian-Spanish (GEIST) registry.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.